SEARCH

SEARCH BY CITATION

References

  • Calmy A, Ford N, Hirschel B et al. (2007) HIV viral load monitoring in resource-limited regions: optional or necessary? Clinical Infectious Diseases 44, 128134.
  • Davies M, Keiser O, Technau K et al. (2009) Outcomes of the South African National Antiretroviral Treatment (ART) programme for children – the IeDEA Southern Africa Collaboration. South African Medical Journal 99, 730737.
  • Davies M, Boulle A, Eley B et al. (2011) Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy – the IeDEA Southern Africa Collaboration. Tropical Medicine and International Health 16, 13671371.
  • Glencross DK, Janossy G, Coetzee LM et al. (2008) Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry. Part B, Clinical Cytometry 74, S131S140.
  • Jittamala P, Puthanakit T, Chaiinseeard S & Sirisanthana V (2009) Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. The Pediatric Infectious Disease Journal 28, 826830.
  • National Institutes of Health (2008) Guidelines for the use of antiretroviral agents in Pediatric HIV infection [Online]. Available: http://AIDSinfo.nih.gov (accessed 17 December 2008).
  • Orrell C, Harling G, Lawn SD et al. (2007) Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antiviral Therapy 12, 8388.
  • Rewari BB, Bachani D, Rajasekaran S, Deshpande A, Chan PL & Srikantiah P (2010) Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing. Journal of Acquired Immune Deficiency Syndromes 55, 610614.
  • Ruel TD, Kamya MR, Li P et al. (2011) Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. Journal of Acquired Immune Deficiency Syndromes 56, 4450.
  • Schneider K, Puthanakit T, Kerra S et al. (2011) Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings. AIDS 25, 11431151.
  • Sigaloff KC, Hamers RL, Wallis CL et al. (2011) Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. Journal of Acquired Immune Deficiency Syndromes 58, 2331.
  • Stevens W, Wiggill T, Horsfield P, Coetzee L & Scott LE (2005) Evaluation of the NucliSensEasyQ assay in HIV-1-infected individuals in South Africa. Journal of Virological Methods 124, 105110.
  • Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM & Kleijnen J (2004) Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Annals of Internal Medicine 140, 189202.
  • WHO (2010) Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach: 2010 revision. [Online]. Available: http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html (accessed 19 October 2010).
  • Wilson D, Keiluhu AK, Kogrum S et al. (2009) HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 601606.